Basic information
- Name:
Sarpogrelate hydrochloride
- CAS No.:
135159-51-2
- Molecular Structure:
- Formula:
- C24H32ClNO6
- Molecular Weight:
- 466.02
- Deleted CAS:
- 86819-20-7
- Synonyms:
- Butanedioicacid, mono[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl]ester, hydrochloride (9CI);Anplag;MCI 9042;Butanedioicacid,1-[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl]ester, hydrochloride (1:1);
- Boiling Point:
- 585.9 °C at 760 mmHg
- Flash Point:
- 308.1 °C
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Chemistry
Structure of Sarpogrelate hydrochloride (CAS NO.135159-51-2):
IUPAC Name: 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid hydrochloride
Empirical Formula: C24H32ClNO6
Molecular Weight: 465.967
Flash Point: 308.1 °C
Enthalpy of Vaporization: 92.05 kJ/mol
Boiling Point: 585.9 °C at 760 mmHg
Vapour Pressure: 1.43E-14 mmHg at 25°C
Synonyms of Sarpogrelate hydrochloride (CAS NO.135159-51-2): Anplag ; MCI-9042 ; Sarpogrelate HCl ; Butanedioicacid, mono[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl]ester, hydrochloride (9CI) .
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | oral | > 3gm/kg (3000mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
| mouse | LD50 | intraperitoneal | 65mg/kg (65mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: PERITONITIS | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
| mouse | LD50 | intravenous | > 45mg/kg (45mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
| mouse | LD50 | oral | 2550mg/kg (2550mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
| rat | LD50 | intraperitoneal | 108mg/kg (108mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: PERITONITIS | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
| rat | LD50 | intravenous | > 45mg/kg (45mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
| rat | LD50 | oral | 4400mg/kg (4400mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |